6:16 am Acura Pharma announces letter agreement with Pfizer (PFE) providing for the termination of Pfizer’s license to Acura’s AVERSION Technology and the return to Acura of the FDA approved Oxecta (oxycodo
View todays social media effects on ACUR
View the latest stocks trending across Twitter. Click to view dashboard